Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Neumora Therapeutics Inc’s current trading price is -92.49% away from its 52-week high, while its distance from the 52-week low is 111.13%. The stock’s price range over this period has fluctuated between $0.61 and $17.19. The company, operating within the financial sector, had a trading volume of approximately 5.28 million for the day, which was noticeably higher than the average daily share volume of 1.1 million over the last 3 months.
The stock of Neumora Therapeutics Inc (NMRA) is currently priced at $1.29. In the last session, the stock climbed significantly, topping out at $18.0 after opening at $1.29. The day’s lowest price was $1.32 before the stock closed at $1.06.
Neumora Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $17.19 on 10/18/24 and the lowest value was $0.61 on 05/14/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Neumora Therapeutics Inc (NMRA) has experienced a quarterly rise of 70.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 208.65M and boasts a workforce of 110 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9605, with a change in price of -0.4500. Similarly, Neumora Therapeutics Inc recorded 1,215,924 in trading volume during the last 100 days, posting a change of -25.86%.
NMRA Stock Stochastic Average
Today, Neumora Therapeutics Inc’s raw stochastic average for the past 50 days stands at 84.98%, indicating a rise from the raw stochastic average of the last 20 days, which was 82.71%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 74.13% and 57.33% respectively.
NMRA Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -87.49% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -50.00%. Over the past 30 days, the price of NMRA has fallen by 26.47%. And in the last five days, it has surged by 57.01%.
